Pulmonx Corporation (LUNG) Tops Q1 EPS by 2c, Misses on Revenue; Offers FY26 Revenue Guidance

Pulmonx Corporation (NASDAQ: LUNG) reported Q1 EPS of ($0.33), $0.02 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $22.65 million.

GUIDANCE:

Pulmonx Corporation sees FY2026 revenue of $90-92 million, versus the consensus of $90.9 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.

You May Also Be Interested In

• Cerebras Systems (CBRS) Misses Q1 EPS, Revenues Beat
• Lockheed Martin wins $8.4B missile contract modification
• Alphabet added to Dow Jones Industrial Average, Verizon dropped